BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11697099)

  • 1. Drug treatment approved for equine neurological disease.
    FDA Consum; 2001; 35(5):6. PubMed ID: 11697099
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutics for Equine Protozoal Myeloencephalitis.
    Pusterla N; Tobin T
    Vet Clin North Am Equine Pract; 2017 Apr; 33(1):87-97. PubMed ID: 28161037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is your neurologic diagnosis? Equine protozoal myeloencephalitis.
    Javsicas LH; Watson E; MacKay RJ
    J Am Vet Med Assoc; 2008 Jan; 232(2):201-4. PubMed ID: 18275385
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of the activity of ponazuril against Sarcocystis neurona in cell cultures.
    Lindsay DS; Dubey JP; Kennedy TJ
    Vet Parasitol; 2000 Sep; 92(2):165-9. PubMed ID: 10946140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ponazuril 15% oral paste as a treatment for equine protozoal myeloencephalitis.
    Furr M; Kennedy T; MacKay R; Reed S; Andrews F; Bernard B; Bain F; Byars D
    Vet Ther; 2001; 2(3):215-22. PubMed ID: 19746664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short communication: evaluation of the kinetics of antibodies against Sarcocystis neurona in serum from seropositive healthy horses without neurological deficits treated with ponazuril paste.
    Pusterla N; Packham A; Wilson WD; White A; Bellamy P; Renier AC; Conrad PA
    Vet Rec; 2013 Sep; 173(10):249. PubMed ID: 23893215
    [No Abstract]   [Full Text] [Related]  

  • 7. Equine Protozoal Myeloencephalitis: An Updated Consensus Statement with a Focus on Parasite Biology, Diagnosis, Treatment, and Prevention.
    Reed SM; Furr M; Howe DK; Johnson AL; MacKay RJ; Morrow JK; Pusterla N; Witonsky S
    J Vet Intern Med; 2016; 30(2):491-502. PubMed ID: 26857902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of Sarcocystis neurona and equine protozoal myeloencephalitis (EPM).
    Dubey JP; Lindsay DS; Saville WJ; Reed SM; Granstrom DE; Speer CA
    Vet Parasitol; 2001 Feb; 95(2-4):89-131. PubMed ID: 11223193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine protozoal myeloencephalitis.
    Howe DK; MacKay RJ; Reed SM
    Vet Clin North Am Equine Pract; 2014 Dec; 30(3):659-75. PubMed ID: 25441115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum antibodies to Sarcocystis neurona--half the horses in the United States have them!
    MacKay RJ
    J Am Vet Med Assoc; 1997 Feb; 210(4):482-3. PubMed ID: 9040830
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylactic administration of ponazuril reduces clinical signs and delays seroconversion in horses challenged with Sarcocystis neurona.
    Furr M; McKenzie H; Saville WJ; Dubey JP; Reed SM; Davis W
    J Parasitol; 2006 Jun; 92(3):637-43. PubMed ID: 16884012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Sarcocystis neurona from a thoroughbred with equine protozoal myeloencephalitis.
    Bowman DD; Cummings JF; Davis SW; deLahunta A; Dubey JP; Suter MM; Rowland PH; Conner DL
    Cornell Vet; 1992 Jan; 82(1):41-52. PubMed ID: 1740059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence to support horses as natural intermediate hosts for Sarcocystis neurona.
    Mullaney T; Murphy AJ; Kiupel M; Bell JA; Rossano MG; Mansfield LS
    Vet Parasitol; 2005 Oct; 133(1):27-36. PubMed ID: 15970386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of headshaking in three horses by treatment for protozoal myeloencephalitis.
    Moore LA; Johnson PJ; Messer NT; Kline KL; Crump LM; Knibb JR
    Vet Rec; 1997 Sep; 141(11):264-7. PubMed ID: 9316239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equine protozoal myeloencephalitis: mystery wrapped in enigma.
    Dame JB; Cutler TJ; Tanhauser S; Ellison S; Greiner EC; MacKay RJ
    Parasitol Res; 2000 Nov; 86(11):940-3. PubMed ID: 11097304
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of the activity of pyrimethamine, trimethoprim, sulfonamides, and combinations of pyrimethamine and sulfonamides against Sarcocystis neurona in cell cultures.
    Lindsay DS; Dubey JP
    Vet Parasitol; 1999 Apr; 82(3):205-10. PubMed ID: 10348099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screen of drug repurposing library identifies inhibitors of Sarcocystis neurona growth.
    Bowden GD; Land KM; O'Connor RM; Fritz HM
    Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):137-144. PubMed ID: 29547840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on Sarcocystis neurona infections in animals and equine protozoal myeloencephalitis (EPM).
    Dubey JP; Howe DK; Furr M; Saville WJ; Marsh AE; Reed SM; Grigg ME
    Vet Parasitol; 2015 Apr; 209(1-2):1-42. PubMed ID: 25737052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Sarcocystis neurona antibodies in French horses with neurological signs.
    Pitel PH; Pronost S; Gargala G; Anrioud D; Toquet MP; Foucher N; Collobert-Laugier C; Fortier G; Ballet JJ
    Int J Parasitol; 2002 Apr; 32(4):481-5. PubMed ID: 11849644
    [No Abstract]   [Full Text] [Related]  

  • 20. Equine protozoal myeloencephalitis.
    MacKay RJ
    Vet Clin North Am Equine Pract; 1997 Apr; 13(1):79-96. PubMed ID: 9106345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.